Cardiology
Hidden Atrial Dysfunction Identified as Stroke Risk Factor in Heart Muscle Disease Patients
A new study reveals that people with transthyretin amyloid cardiomyopathy face significantly higher stroke risk when they have atrial electromechanical dysfunction, and researchers have developed a noninvasive assessment tool to identify those who might benefit from preventive treatments.
Combined Biomarker Analysis Reveals Triple Heart Attack Risk in High-Risk Individuals
A new study shows that analyzing three specific biomarkers together can identify individuals with nearly triple the risk of heart attack, potentially enabling earlier intervention and personalized prevention strategies.
AI Tool Detects Structural Heart Disease Using Smartwatch ECG Sensors
An artificial intelligence algorithm paired with smartwatch ECG sensors can accurately detect structural heart diseases, potentially making early screening more accessible to millions of people who already own these devices.
HeartBeam to Discuss Q3 2025 Results and Regulatory Progress in November Conference Call
HeartBeam will host a conference call on November 13, 2025, to discuss third-quarter results and provide updates on its FDA-cleared 3D ECG technology that could transform remote cardiac monitoring.
HeartBeam Partners With HeartNexus to Expand Remote Cardiac Monitoring Services
HeartBeam's partnership with HeartNexus enables 24/7 remote cardiology services and real-time ECG interpretation, expanding access to medical-grade cardiac care outside traditional healthcare facilities.
American Heart Association Launches Digital Health Certification to Standardize Cardiac Telemedicine
The American Heart Association has introduced a new professional certification program to standardize digital health training for cardiac care providers as telehealth adoption expands rapidly.
HeartBeam's Portable ECG Technology Poised to Transform Cardiac Care with Medical-Grade Accuracy
HeartBeam is advancing a portable, credit-card-sized device that captures three-dimensional heart signals and reconstructs them into synthesized 12-lead ECGs, potentially enabling earlier detection of heart rhythm problems and reducing hospitalizations through accessible, patient-centered cardiac monitoring.
HeartBeam's Portable ECG Technology Poised to Transform Cardiac Care Delivery
HeartBeam Inc. is advancing a portable, credit-card-sized device that captures three-dimensional heart signals and reconstructs them into full 12-lead ECGs, potentially enabling earlier detection and treatment of heart conditions outside medical facilities.
NFL Players Lead National CPR Awareness Campaign on World Restart a Heart Day
The American Heart Association and NFL have launched the 2025 Nation of Lifesavers initiative with 30 player ambassadors to address the critical need for CPR education, as immediate intervention can double or triple survival rates for sudden cardiac arrest victims.
UT Southwestern Cardiologist Amit Khera Receives Prestigious 2025 Chairman's Award from American Heart Association
Dr. Amit Khera's recognition highlights his transformative contributions to preventive cardiology, including developing NASA's astronaut heart risk calculator and advancing cardiovascular disease prevention through innovative research and leadership.
HeartBeam Validates Portable ECG Technology in Pivotal Study
HeartBeam's portable ECG device demonstrates strong correlation with traditional 12-lead ECGs in clinical study, potentially revolutionizing remote cardiac monitoring for heart rhythm problems.
NYU's Judith Hochman to Receive 2025 Research Achievement Award for Transformative Cardiology Research
Dr. Judith Hochman's recognition by the American Heart Association highlights her pivotal clinical trials that have reshaped global cardiology guidelines and improved patient outcomes in ischemic heart disease.
HeartBeam's Portable ECG System Aims to Transform Remote Cardiac Monitoring
HeartBeam is developing the first cable-free 12-lead ECG system that enables comprehensive arrhythmia assessment outside clinical settings, potentially revolutionizing how patients monitor heart health remotely.
HeartBeam's Portable ECG System Aims to Transform Cardiac Care Accessibility
HeartBeam Inc. is developing a credit card-sized, cable-free ECG system that enables comprehensive arrhythmia assessment outside clinical settings, potentially revolutionizing remote cardiac monitoring.
HeartBeam's Cable-Free ECG System Enables Multi-Angle Cardiac Monitoring for At-Home Arrhythmia Detection
HeartBeam Inc.'s FDA-cleared cable-free ECG device captures heart signals from three distinct directions, potentially improving diagnostic precision for arrhythmias and enabling timely at-home cardiac monitoring.
Psychological Distress After Heart Attack Linked to Increased Risk of Future Cardiac Events
New research reveals that psychological distress affects up to 50% of heart attack survivors and increases the risk of future cardiac events by 1.3 to 2 times, highlighting the critical need for integrated mental health care in cardiac recovery.
HeartBeam Nears FDA Clearance for Revolutionary ECG Technology Set to Transform Cardiac Monitoring
HeartBeam is preparing for the commercial launch of its innovative 12-lead ECG synthesis software, which could significantly improve arrhythmia detection in both clinical and home settings pending FDA clearance expected by year-end.
HeartBeam Advances Revolutionary ECG Technology Toward FDA Clearance and Commercial Launch
HeartBeam Inc. is preparing for the commercial launch of its innovative 12-lead ECG synthesis software for arrhythmia assessment, which could transform cardiac diagnostics in both clinical and home settings pending FDA clearance expected by year-end.
HeartBeam Develops First Cable-Free 12-Lead ECG System for At-Home Cardiac Monitoring
HeartBeam Inc. is advancing cardiac care with its innovative cable-free ECG system that enables comprehensive arrhythmia assessment outside clinical settings, addressing limitations of traditional ECG technology.
HeartBeam Study Shows Comparable Accuracy to Standard ECG in Arrhythmia Detection
HeartBeam's 3D ECG system demonstrates comparable accuracy to standard 12-lead ECGs in detecting arrhythmias, potentially expanding advanced cardiac monitoring to non-clinical settings.
HeartBeam Study Shows Comparable Accuracy Between Portable 3D ECG System and Standard 12-Lead ECG
HeartBeam Inc. reported study results demonstrating that its portable 3D ECG system achieves comparable accuracy to standard 12-lead ECGs in detecting cardiac arrhythmias, potentially expanding advanced cardiac monitoring to non-clinical settings.
New Research Reveals 62% of AFib Patients Unaware of Condition Before Diagnosis
A new American Heart Association study shows most atrial fibrillation patients were unaware of their condition before diagnosis, highlighting critical gaps in public awareness about this serious heart rhythm disorder that significantly increases stroke risk.
HeartBeam's Portable ECG Device Enables Hospital-Level Cardiac Monitoring Outside Clinical Settings
HeartBeam's credit-card-sized FDA-cleared device synthesizes 12-lead ECGs from 3D signals, potentially transforming remote cardiac care by providing on-demand arrhythmia evaluation and integration with automated interpretation software.
HeartBeam to Showcase FDA-Cleared Cardiac Technology at Major Investor Conferences
HeartBeam Inc. executives will present the company's innovative cable-free 3D ECG technology at three September investor conferences, highlighting progress in commercializing a device that could transform remote cardiac care.
HeartBeam's Cable-Free ECG Technology Advances At-Home Cardiac Monitoring
HeartBeam's FDA-cleared portable ECG system enables patients to capture high-fidelity heart measurements at home, potentially improving early detection of arrhythmias and transforming cardiac care through convenient remote monitoring.
HeartBeam Receives FDA Clearance for Revolutionary Cable-Free ECG System
HeartBeam Inc. has obtained FDA clearance for its groundbreaking cable-free 12-lead ECG system that enables remote cardiac monitoring, potentially transforming how patients and physicians access critical arrhythmia data outside traditional clinical settings.
American Heart Association Launches Virtual Care Program to Reduce Heart Failure Readmissions
The American Heart Association's new Connected Care program addresses critical gaps in post-discharge heart failure care through remote monitoring technology, aiming to reduce hospital readmissions and improve long-term patient outcomes.
Boone Heart Institute to Host Summit Conference 2025 Focused on Preventive Cardiology Advancements
The Boone Heart Institute's Summit Conference 2025 in Denver will bring together healthcare professionals to address atherosclerosis, the world's leading cause of death, through cutting-edge research and clinical innovations in preventive cardiology.
HeartBeam Secures New Patents to Advance 3D ECG Technology for Remote Cardiac Monitoring
HeartBeam Inc. has strengthened its intellectual property portfolio with two new U.S. patents that enhance its innovative 3D ECG platform, positioning the company to transform remote cardiac care by enabling patients and physicians to monitor and diagnose heart conditions outside medical facilities.
NeuralBase AI Submits HeartEase App for Google Play Store Review, Expanding Access to AI-Powered Heart Health Support
NeuralBase AI Ltd. has submitted its HeartEase app for Google Play Store review, aiming to provide Android users worldwide with AI-driven health and wellness support for heart health.